Barrington Research Raises U.S. Physical Therapy (NYSE:USPH) Price Target to $98.00

U.S. Physical Therapy (NYSE:USPH) had its price target lifted by equities research analysts at Barrington Research from $90.00 to $98.00 in a report issued on Monday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Barrington Research’s price target suggests a potential upside of 22.67% from the company’s previous close.

USPH has been the subject of several other reports. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of U.S. Physical Therapy in a report on Friday, May 29th. Citizens Jmp reaffirmed a “market outperform” rating and issued a $98.00 target price on shares of U.S. Physical Therapy in a research report on Wednesday, June 24th. Zacks Research raised shares of U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a report on Wednesday, May 27th. Finally, Citigroup reiterated a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Friday, July 24th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, U.S. Physical Therapy currently has an average rating of “Moderate Buy” and an average price target of $99.50.

U.S. Physical Therapy Price Performance

Shares of USPH opened at $79.89 on Monday. U.S. Physical Therapy has a 52 week low of $58.19 and a 52 week high of $93.50. The company has a current ratio of 1.27, a quick ratio of 1.19 and a debt-to-equity ratio of 0.48. The firm has a market cap of $1.22 billion, a price-to-earnings ratio of 469.97, a PEG ratio of 2.18 and a beta of 1.13. The stock has a 50 day moving average of $70.17 and a 200-day moving average of $74.15.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Wednesday, August 5th. The company reported $0.75 EPS for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.06). U.S. Physical Therapy had a return on equity of 9.39% and a net margin of 3.97%.The business had revenue of $214.06 million during the quarter, compared to analyst estimates of $211.36 million. During the same period in the prior year, the firm earned $0.81 EPS. The business’s revenue for the quarter was up 8.5% compared to the same quarter last year. As a group, analysts forecast that U.S. Physical Therapy will post 2.98 EPS for the current year.

Insider Activity at U.S. Physical Therapy

In related news, Director Peter Francis Minan purchased 492 shares of U.S. Physical Therapy stock in a transaction dated Monday, June 8th. The stock was bought at an average cost of $63.14 per share, with a total value of $31,064.88. Following the purchase, the director owned 2,923 shares in the company, valued at approximately $184,558.22. The trade was a 20.24% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 2.40% of the company’s stock.

Hedge Funds Weigh In On U.S. Physical Therapy

A number of institutional investors and hedge funds have recently added to or reduced their stakes in USPH. Hantz Financial Services Inc. increased its position in shares of U.S. Physical Therapy by 56.4% during the 4th quarter. Hantz Financial Services Inc. now owns 366 shares of the company’s stock valued at $29,000 after purchasing an additional 132 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in shares of U.S. Physical Therapy in the second quarter valued at $30,000. Advisory Services Network LLC bought a new position in U.S. Physical Therapy during the third quarter valued at about $39,000. iSAM Funds UK Ltd bought a new position in U.S. Physical Therapy during the third quarter valued at about $52,000. Finally, Parallel Advisors LLC grew its holdings in U.S. Physical Therapy by 75.2% during the first quarter. Parallel Advisors LLC now owns 785 shares of the company’s stock worth $59,000 after acquiring an additional 337 shares during the period.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.